Scott Rocklage - Founding Partner @ 5AM Ventures

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

110,268

Primary Job Title Founding Partner
Primary Organization
5AM Ventures

Gender Male

Investor Type
obfuscated
obfuscation

Scott Michael Rocklage is based out of Palm Beach Gardens, Florida and currently works as a Founding Partner for 5AM Ventures. Scott previously worked at Cubist Pharmaceuticals as a Chairman and CEO. Scott Michael Rocklage attended the University of California Berkeley.

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Nouscom	5AM Ventures	—	Series C - Nouscom	obfuscated obfuscation
obfuscated obfuscation	Expansion Therapeutics	5AM Ventures	—	Series B - Expansion Therapeutics	obfuscated obfuscation
obfuscated obfuscation	NodThera	5AM Ventures	—	Series B - NodThera	obfuscated obfuscation
obfuscated obfuscation	NodThera	5AM Ventures	Yes	Series A - NodThera	obfuscated obfuscation
obfuscated obfuscation	Expansion Therapeutics	5AM Ventures	Yes	Series A - Expansion Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Nouscom	5AM Ventures	—	Series B - Nouscom	obfuscated obfuscation
obfuscated obfuscation	Aprea	5AM Ventures	Yes	Series B - Aprea	obfuscated obfuscation
obfuscated obfuscation	Pulmatrix	5AM Ventures	—	Post-IPO Equity - Pulmatrix	obfuscated obfuscation
obfuscated obfuscation	Novira Therapeutics	5AM Ventures	Yes	Series A - Novira Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Achaogen	5AM Ventures	—	Series D - Achaogen	obfuscated obfuscation

Jobs

Number of Current Jobs

Number of Past Jobs

Scott Rocklage

is the

Founding Partner

5AM Ventures

. Additionally,

Scott Rocklage

has had

past jobs including

Executive Chairman

CASI Pharmaceuticals

5AM Ventures Founding Partner2017

Organization Name	Title At Company	Start Date	End Date
CASI Pharmaceuticals	Executive Chairman	—	—
Cubist Pharmaceuticals	Chairman and CEO	—	—
Catalytica	R&D positions	—	—
Ilypsa	Executive Chairman	—	—
Relypsa	Executive Chairman	—	—
Nycomed Salutar,	President and CEO	—	—

Board and Advisor Roles

Number of Current Board & Advisor Roles

Number of Past Board & Advisor Roles

Scott Rocklage

holds

board and advisor roles including

Board Member

NodThera

Board Member

WaveRx

, and

Board Member

VBI Vaccines

NodThera Board MemberJun 2018
WaveRx Board Member
VBI Vaccines Board Member
Novira Therapeutics Board of Directors
Pulmatrix Board of Directors
Relypsa Board Chairman
Nouscom Board of Directors
Whitehead Institute for Biomedical Research Board of Associates
Achaogen Board Chairman
Expansion Therapeutics Chairman

Organization Name	Title At Company	Start Date	End Date
Epirus Biopharmaceuticals	Board of Director	Jan 27, 2011	Dec 2, 2015
Rennovia	Board of Directors	—	—

Related Hubs

Hub Name	CB Rank (Hub)
Investors with Funds Raised in 2002	57,967
Investors with Funds Raised in 2010	29,362
Investors with Funds Raised in 2009	31,334
Montgomery Securities Alumni Founded Companies	88,601
Investors with Funds Raised in 2006	38,947
Post IPO Investors Venture Capital Investors	25,567
Affymetrix Alumni Founded Companies	95,640